Feedback / Questions
AX-8 - Axalbion
https://www.businesswire.com/news/home/20240827634169/en/Axalbion-Therapeutics-Announces-First-Patient-Dosed-in-Phase-2-Clinical-Study-in-Chronic-Cough-with-AX-8-a-Novel-TRPM8-Agonist
Aug 27, 2024
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next